In order to address the increasing subset of lean NAFLD patients and reappraise BMI-approached MAFLD, further investigations are needed to explore the mechanisms connecting fetuin-A to lean NAFLD as well as their clinical application. Here, AHSG is linked to metabolic dysfunction-associated steatotic liver disease.